Under construction – not a live service
Sign in
Taking people in PortugalNo phase

Heart Changes After Endovascular Repair of the Aorta

Studies heart shape and function with MRI in adults after aortic repair.

Plain-language title generated from the registry record
Registry title: Cardiac Remodelling Following Endovascular Repair of the Aorta

Key facts

Where
Lisbon, PortugalSee the 2 sites

Where in Portugal

  • Unidade Local De Saude De Santa Maria E.P.E.Lisbon, PortugalNot yet recruiting
  • Unidade Local de Saúde Santa MariaLisbon, PortugalTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
Trial code
NCT07415447
Record updated
17 February 2026
Original description
To assess the effects of endovascular aortic repair on cardiac morphology and functionRead full original descriptionShow less

Cardiac Remodelling Following Endovascular Repair of the Aorta

To assess the effects of endovascular aortic repair on cardiac morphology and function

Inclusion: Patients over 18-year-old, with degenerative arch, descending thoracic or abdominal aortic aneurysms, penetrating aortic ulcers or intramural hematomas managed with total EVAR in elective setting.

Exclusion: CMR contraindications (non-compatible pacemakers and metal implants, and claustrophobia); Moderate to severe valve disease; History of (or expected within the study period) cardiac/aortic surgery; Coronary artery disease; Congenital heart disease; Connective tissue disorders; Moderate to severe pulmonary disease as indicate either by post bronchodilator FEV1 (%predicted) <50% or Modified Medical Research Council Dyspnoea Scale (mMRC) 3-4; Heart failure with an ejection fraction <35 vs 50% or New York Heart Association (NYHA) class III and IV; Chronic kidney disease (eGFR <30 mL/min/173 m2); LV wall motion abnormality; Atrial fibrillation.

ClinicalTrials.gov NCT07415447